Acclarent is a medical device company that develops new technologies to treat patients suffering from ENT disorders.
Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients.Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 12, 2009 | Series Unknown | $26M | 1 | — | — | Detail |
Apr 23, 2007 | Series C | $35M | 1 | — | — | Detail |
Dec 20, 2005 | Series B | $25M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series Unknown |